CTLA-4 Antibody (Hu111) [Unconjugated]

HEK293 Human cell line transfected with (A) Human CTLA-4 or (B) irrelevant transfectants and eGFP was stained with Human Anti-Human CTLA-4 (Research Grade Ipilimumab) Monoclonal Antibody (Catalog # MAB9928) followed by APC-conjugated Anti-Human IgG Secondary Antibody (Catalog # F0135). View our protocol for Staining Membrane-associated Proteins.

• Reactivity: Hu
• Applications: Flow, CyTOF-ready
• Clone: Hu111
• Clonality: Monoclonal
• Host: Human
• Conjugate: Unconjugated

CTLA-4 Antibody (Hu111) [Unconjugated] Summary

• Additional Information: Recombinant Monoclonal Antibody For Research Use Only
• Immunogen: Human CTLA-4
• Specificity: Detects Human CTLA-4 based on Ipilimumab therapeutic antibody.This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. This product is for research use only.
• Source: N/A
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Human

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 0.25 ug/10^6 cells
  • CyTOF-ready
• Control:

  CTLA-4 Knockout HeLa Cell Lysate

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
• Reconstitution Instructions: Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CTLA-4 Antibody (Hu111) [Unconjugated]

• CD
• CD152 antigen
• CD152
• CD152IDDM12
• CD28
• celiac disease 3
• CELIAC3
• CTLA4
• CTLA-4
• cytotoxic T-lymphocyte antigen 4
• cytotoxic T-lymphocyte protein 4
• Cytotoxic T-lymphocyte-associated antigen 4
• cytotoxic T-lymphocyte-associated protein 4
• cytotoxic T-lymphocyte-associated serine esterase-4
• GRD4
• GSE
• ICOS
• ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4

Background

Ipilimumab is a biosimilar directed against the extracellular domain of CTLA‑4. This product constitutes the immunogen used for the anti-Idiotype catalog number MAB10064. The biotinylated antibody (catalog number FAB9928B) can be used in flow cytometry or various assay format to measure CTLA-4 expression and can be detected by conjugated streptavidin.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.